FibroBiologics to Present at the BIO Investment & Growth Summit
HOUSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued...
Month: February 2026
GATC Health Strengthens Commercial and Pharma Strategy Leadership to Accelerate Market Adoption of Its AI Platform
Mark Flather and Dr. Fred Brown join to expand adoption of Derisq™ and Operon™, delivering AI-powered risk prediction and portfolio...
NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome
Videos on the NETHERTON NOW website have been viewed 2 million times with 24 million impressions Patients, families, and clinicians...
Glow Holdings, Inc. Launches New Corporate Website
HOUSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Glow Holdings, Inc. (OTC: GLOH), doing business as GlohCo, an emerging healthtech company...
RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting
Accepted Abstract Highlights Metabolic Response Observations Following Chemotherapeutic Drug-Delivery via the TAMP™ Therapy Platform in Patients Diagnosed with Locally Advanced...
PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the...
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
Results from IV Phase 1 SAD/MAD Trial Expected in 2026JERSEY CITY, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc....
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
Physician Interview Now AvailableKey Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction...
Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product
Raanana, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company...
ImageneBio to Participate in Leerink Global Healthcare Conference
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” or the “Company”), today announced management will...
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of...
Aleen Inc. Announces Its Listing on the Frankfurt Stock Exchange
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, is pleased to announce...
LevelJump Announces Grant of Stock Options
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("Leveljump" or the "Company") announces that, pursuant...
OTF + Lilly Collaboration Update on Registration Response | OMA QI Scaling Initiative Gains National Response, Bringing Together Diverse Practice Types Across 39 States
Denver, Colorado--(Newsfile Corp. - February 26, 2026) - The Obesity Medicine Association (OMA) is seeing strong early momentum for its...
Rock Salt Marketing Ranked Among Best SEO Agencies in the USA on DesignRush
Recognition reflects the agency's national SEO work spanning technical optimization, multi-location search strategy, and revenue-focused organic growth.Salt Lake City, Utah--(Newsfile...
Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
First Patients of 2026 Treated Outside of Sponsor-Led Clinical Trials Under Australia's Regulated FrameworkVancouver, British Columbia--(Newsfile Corp. - February 26,...
TempraMed Reports over 275 Clinicians Recommending VIVI Cap to Patients on Leading FrontrowMD Platform Across the United States
Partnership results in over 275 physicians recommending VIVI Cap to patients, strengthening clinical validation and driving scalable patient education and...
Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences
Global expansion of advanced mutagenesis testing services supports regulatory genetic toxicology and next-generation genomic safety assessmentEJBY, Denmark, Feb. 26, 2026...
Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call
HOUSTON, Feb. 25, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27...
Healthcare Triangle Subsidiary QuantumNexis and TNG Digital, the Operator of Malaysia’s Leading Digital Financial Services and Lifestyle App, Announce Strategic Partnership to Provide Digital Mental Health Solutions to Its Over 25 Million Customers in Malaysia
The partnership strengthens Healthcare Triangle's leadership at the intersection of digital health, fintech, and population-scale care delivery.PLEASANTON, Calif., Feb. 25, 2026...